AI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuation
By
Amy Feldman
Summary
AI drug discovery startup Chai Discovery, founded just 15 months ago, released an antibody-designing AI model that generated intense interest from nearly 20 pharmaceutical companies. The startup is now working with major drugmakers including Pfizer and Eli Lilly to use its AI for finding new therapies, and is in talks to raise $400 million at a $3.4 billion valuation. The article highlights how AI is poised to disrupt the costly and time-intensive drug discovery process, where a single drug typically costs over $1 billion to develop.
Source
bskyAI Drug Discovery Startup Chai Discovery Attracts Pfizer, Eli Lilly; Seeks $400M at $3.4B Valuationforbes.comKey quotes
· 2 pulledIt was like we dropped a bomb on the field
People were messaging on LinkedIn at 2 a.m., saying, 'I am so excited I can't sleep.'
You might also wanna read

Takeda signs $600M AI drug discovery deal with Insilico
Verge Genomics Hiring for Engineering and Product Roles to Advance AI Drug Discovery
Verge Genomics, an AI drug discovery company, is hiring for multiple engineering and product roles including Head of Product & Engineering,
AI Startup Thinking Machines Raises $2 Billion at $12 Billion Valuation
Thinking Machines Lab, an AI startup founded by Mira Murati, raised $2 billion at a $12 billion valuation in a funding round led by Andreess
Yann LeCun's AI Startup AMI Labs Raises Over $1 Billion in Record European Seed Round
Meta's former chief AI scientist Yann LeCun has launched a new AI startup called AMI Labs, which has raised over $1 billion in Europe's larg
Harmonic Discovery: AI-powered platform for precision drug design launches on Product Hunt
Harmonic Discovery is a biotech platform that uses machine learning and generative chemistry to design safer, more effective medicines. The
Tamarind Bio: AI Inference Platform for Drug Discovery Models
Tamarind Bio is an AI inference provider for drug discovery that offers a platform for biopharma companies to run leading open-source AI mod

Comments
Sign in to join the conversation.
No comments yet. Be the first.